Literature DB >> 32995198

Three-Minute Step Test for Predicting Acute Mountain Sickness: A Post Hoc Analysis of Rhodiola Crenulata Extract for Prevention of Acute Mountain Sickness, a Randomized, Double-Blind, Placebo-Controlled, Crossover Trial.

Hsiang Yun Lo1,2, Lisa Li-Chuan Chen3, Deng-Huang Su4, Chung-Hsien Chen5, Tai-Yi Hsu6, Shih-Hao Wang7,8, Yi-Ming Weng2,9, Cheng-Wei Chan2,10, Shih-Hao Wu2, Hang-Cheng Chen6, Te-Fa Chiu6.   

Abstract

BACKGROUND: Acute mountain sickness (AMS) often occurs in individuals who rapidly travel above 2,500 m. As the convenience of traveling and the development of mountain sports increase, AMS will become an increasingly important public health problem. However, no method to effectively predict AMS before it occurs is currently available.
METHODS: This post hoc study investigated whether the 3-Minute Step Test (3MST), which evaluates physical fitness, is predictive of AMS development. The data collected in "Rhodiola crenulata extract for prevention of AMS: a randomized, double-blind, placebo-controlled, crossover trial" was used in the analysis. This study collected 204 observations of 102 participants who made two ascents of Hehuan Mountain (3,100 m) by bus within a 3-month period. Participants completed the 3MST at 250 m (before ascent) and 3,100 m (on Hehuan Mountain). The presence of AMS was accessed using the Lake Louise scoring system.
RESULTS: AMS was identified in 124 observations (60.78%). In the univariate analysis, the pre-departure 3MST score (at 250 m) was not significantly associated with AMS (p = 0.498), but the 3MST score measured at 3,100 m, ascent number, pulse rate at 3,100 m, and saturation of peripheral oxygen (SpO2) measured at 3,100 m were significantly correlated with the occurrence of AMS (p = 0.002, 0.039, 0.005, < 0.001, respectively). In a further multivariate analysis, only SpO2 measured at 3,100 m had a significant association with AMS (p = 0.016 and 0.006, respectively). The trend analysis showed that for every 1-point increase in the 3MST score at 3,100 m, the AMS decreased by 4% (adjusted odds ratio [AOR] = 0.96, 95% confidence interval [CI] = 0.92-1.01).
CONCLUSION: The 3MST score cannot be a predictor of AMS, but it may have a potential role in predicting ascent safety in high-altitude areas.
Copyright © 2018 by Taiwan Society of Emergency Medicine & Ainosco Press. All Rights Reserved.

Entities:  

Keywords:  acute mountain sickness; fitness; three-Minute Step Test

Year:  2018        PMID: 32995198      PMCID: PMC7517883          DOI: 10.6705/j.jacme.201803_8(1).0004

Source DB:  PubMed          Journal:  J Acute Med        ISSN: 2211-5587


  27 in total

Review 1.  High-altitude illness.

Authors:  P H Hackett; R C Roach
Journal:  N Engl J Med       Date:  2001-07-12       Impact factor: 91.245

2.  Acute mountain sickness in Jade Mountain climbers of Taiwan.

Authors:  Wei-Fong Kao; Chien-Chun Kuo; Teh-Fu Hsu; Hsing Chang; Ying-Ying Sung; David H T Yen; Jer-Kan Wu; Chen-Hsen Lee
Journal:  Aviat Space Environ Med       Date:  2002-04

3.  Epidemiology of acute mountain sickness on Jade Mountain, Taiwan: an annual prospective observational study.

Authors:  Shih-Hao Wang; Yu-Cheng Chen; Wei-Fong Kao; Yu-Jr Lin; Jih-Chang Chen; Te-Fa Chiu; Tai-Yi Hsu; Hang-Cheng Chen; Shih-Wei Liu
Journal:  High Alt Med Biol       Date:  2010       Impact factor: 1.981

4.  Prediction of acute mountain sickness by monitoring arterial oxygen saturation during ascent.

Authors:  Heikki M Karinen; Juha E Peltonen; Mika Kähönen; Heikki O Tikkanen
Journal:  High Alt Med Biol       Date:  2010       Impact factor: 1.981

5.  Determinants of acute mountain sickness and success on Mount Aconcagua (6962 m).

Authors:  Carlos Pesce; Conxita Leal; Hernán Pinto; Gabriela González; Marco Maggiorini; Michael Schneider; Peter Bärtsch
Journal:  High Alt Med Biol       Date:  2005       Impact factor: 1.981

Review 6.  Acute altitude illnesses.

Authors:  Chris Imray; Adam Booth; Alex Wright; Arthur Bradwell
Journal:  BMJ       Date:  2011-08-15

7.  Prevalence of acute mountain sickness in the Swiss Alps.

Authors:  M Maggiorini; B Bühler; M Walter; O Oelz
Journal:  BMJ       Date:  1990-10-13

8.  Acute mountain sickness in a general tourist population at moderate altitudes.

Authors:  B Honigman; M K Theis; J Koziol-McLain; R Roach; R Yip; C Houston; L G Moore; P Pearce
Journal:  Ann Intern Med       Date:  1993-04-15       Impact factor: 25.391

9.  Three-minute step test to assess exercise capacity in children with cystic fibrosis with mild lung disease.

Authors:  I Narang; S Pike; M Rosenthal; I M Balfour-Lynn; A Bush
Journal:  Pediatr Pulmonol       Date:  2003-02

10.  How can acute mountain sickness be quantified at moderate altitude?

Authors:  G Roeggla; M Roeggla; A Podolsky; A Wagner; A N Laggner
Journal:  J R Soc Med       Date:  1996-03       Impact factor: 18.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.